Skip to main content

Table 1 Immunohistochemical expression analysis of the CXCR4-CXCL12 axis in Ewing sarcoma

From: The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease

UPNa

sample type (years after diagnosis)

CXCR4b

CXCL12

   

tumor

stroma

1

lung metastasis (3)

-

-

+/−

 

bone metastasis (7)

-

-

+/−

2

lung metastasis (2)

-

+

+

3

therapy-naive biopsy

+/−

+

+

 

lung metastasis (5,5)

-

-

+/−

4

therapy-naive biopsy

++

+/−

+

 

lung metastasis (3)

-

+

++

 

lung metastasis (4)

-

+

++

5

therapy-naive biopsy

++

+/−

++

 

bone metastasis (1)

n.e.

+/−

+

6

therapy-naive biopsy

+

++

n.e.

 

lung metastasis (1)

+/−

+/−

+/−

7

therapy-naive biopsy

++

++

+

8

therapy-naive biopsy

++

+/−

+

 

bone metastasis (2,5)

+

++

++

9

therapy-naive biopsy

-

+

+

 

lung metastasis (0,5)

+

+

++

10

therapy-naive biopsy

+

-

+/−

11

therapy-naive biopsy

-

+

+/−

12

therapy-naive biopsy

+

+/−

+

13

therapy-naive biopsy

++

-

+/−

14

therapy-naive biopsy

-

+/−

+

15

therapy-naive biopsy

-

-

+/−

16

therapy-naive biopsy

-

+

+/−

17

therapy-naive biopsy

-

+

+

18

therapy-naive biopsy

+

+/−

+/−

19

therapy-naive biopsy

-

+/−

+

20

therapy-naive biopsy

+/−

-

+

21

therapy-naive biopsy

-

-

+/−

22

therapy-naive biopsy

-

-

-

23

therapy-naive biopsy

-

+/−

+/−

24

therapy-naive biopsy

+/−

+/−

+/−

25

therapy-naive biopsy

++

-

-

26

therapy-naive biopsy

-

+

+

27

therapy-naive biopsy

+

+/−

+

28

therapy-naive biopsy

++

+/−

+

29

therapy naive biopsy

-

-

+/−

30

therapy-naive biopsy

++

++

+

31

therapy-naive biopsy

+

-

++

32

therapy-naive biopsy

+

+

+

33

therapy-naive biopsy

-

-

+/−

34

therapy-naive biopsy

++

+

+

35

therapy-naive biopsy

+

-

+/−

36

therapy-naive biopsy

+

+

+

37

therapy-naive biopsy

+

-

+

38

therapy-naive biopsy

++

n.e.

n.e.

39

therapy-naive biopsy

++

-

+/−

40

therapy-naive biopsy

-

-

+/−

41

therapy-naive biopsy

+

+

+

42

therapy-naive biopsy

+

-

+/−

43

therapy-naive biopsy

-

++

+

44

therapy-naive biopsy

-

+

+

45

lung metastasis (1,5)

+/−

+/−

++

 

bone metastasis (2,5)

++

+/−

+

 

lung metastasis (2,5)

-

+

++

 

lung metastasis (4)

-

+/−

++

 

lung metastasis (4)

+/−

+/−

+

 

lung metastasis (5)

+

+

+

46

therapy-naive biopsy

+

+

+

47

therapy-naive biopsy

+/−

++

++

  1. aUPN = unique patient number. n.e. = not evaluable; - = absent expression; ‘+/− = weak expression; + = moderate expression; ++ = strong expression. bt-test: therapy-naive Ewing sarcoma demonstrated significantly higher CXCR4 expression levels as compared to metastatic lesions (p = 0.027).